AU2018902782A0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU2018902782A0
AU2018902782A0 AU2018902782A AU2018902782A AU2018902782A0 AU 2018902782 A0 AU2018902782 A0 AU 2018902782A0 AU 2018902782 A AU2018902782 A AU 2018902782A AU 2018902782 A AU2018902782 A AU 2018902782A AU 2018902782 A0 AU2018902782 A0 AU 2018902782A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018902782A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auscann Group Holdings Ltd
Original Assignee
Auscann Group Holdings Ltd
Filing date
Publication date
Application filed by Auscann Group Holdings Ltd filed Critical Auscann Group Holdings Ltd
Publication of AU2018902782A0 publication Critical patent/AU2018902782A0/en
Priority to EP19845034.8A priority Critical patent/EP3829554A4/en
Priority to CA3107014A priority patent/CA3107014A1/en
Priority to JP2021529492A priority patent/JP2021533202A/en
Priority to BR112021001406-3A priority patent/BR112021001406A2/en
Priority to US17/263,645 priority patent/US20210290552A1/en
Priority to PCT/AU2019/050801 priority patent/WO2020024009A1/en
Priority to AU2019313160A priority patent/AU2019313160A1/en
Priority to CN201980050455.5A priority patent/CN112638369A/en
Priority to PCT/AU2019/050803 priority patent/WO2020024011A1/en
Priority to KR1020217005833A priority patent/KR20210055042A/en
Priority to IL280540A priority patent/IL280540A/en
Abandoned legal-status Critical Current

Links

AU2018902782A 2018-07-31 2018-07-31 Pharmaceutical formulation Abandoned AU2018902782A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
KR1020217005833A KR20210055042A (en) 2018-07-31 2019-07-30 “Solid self-emulsifying pharmaceutical composition”
US17/263,645 US20210290552A1 (en) 2018-07-31 2019-07-30 Solid self-emulsifying pharmaceutical compositions
CA3107014A CA3107014A1 (en) 2018-07-31 2019-07-30 Solid self-emulsifying pharmaceutical compositions
JP2021529492A JP2021533202A (en) 2018-07-31 2019-07-30 Solid self-emulsifying pharmaceutical composition
BR112021001406-3A BR112021001406A2 (en) 2018-07-31 2019-07-30 solid self-emulsifying pharmaceutical compositions
EP19845034.8A EP3829554A4 (en) 2018-07-31 2019-07-30 Solid self-emulsifying pharmaceutical compositions
PCT/AU2019/050801 WO2020024009A1 (en) 2018-07-31 2019-07-30 "solid self-emulsifying pharmaceutical compositions"
AU2019313160A AU2019313160A1 (en) 2018-07-31 2019-07-30 "solid self-emulsifying pharmaceutical compositions"
CN201980050455.5A CN112638369A (en) 2018-07-31 2019-07-30 Solid self-emulsifying pharmaceutical composition
PCT/AU2019/050803 WO2020024011A1 (en) 2018-07-31 2019-07-30 Free-flowing powder compositions
IL280540A IL280540A (en) 2018-07-31 2021-01-31 Solid self-emulsifying pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU2018902782A0 true AU2018902782A0 (en) 2018-08-16

Family

ID=

Similar Documents

Publication Publication Date Title
GB201807942D0 (en) Pharmaceutical formulation
EP4045480A4 (en) Pharmaceutical formulations
EP3641771A4 (en) Pharmaceutical compositions
EP3541385A4 (en) Pharmaceutical formulations
EP3802562A4 (en) New pharmaceutical use
EP3452075A4 (en) Ophthalmic pharmaceutical composition
EP3603642A4 (en) Pharmaceutical preparation
EP3709978B8 (en) Pharmaceutical oral formulation comprising bacteria
AU2018302170A1 (en) Pharmaceutical compositions comprising entrectinib
EP3581183A4 (en) Tumor-treating pharmaceutical composition
SG11202010124SA (en) Stable pharmaceutical formulation
ZA202102871B (en) Pharmaceutical formulation
IL278927A (en) Pharmaceutical formulation
EP3583943A4 (en) Pharmaceutical composition
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
IL290894A (en) Pharmaceutical formulation
EP3646866A4 (en) Pharmaceutical preparation
AU2016218074B2 (en) Pharmaceutical formulation
EP3868371A4 (en) Novel pharmaceutical composition
EP3383371A4 (en) Pharmaceutical formulation
EP3646867A4 (en) Pharmaceutical composition
EP3946296A4 (en) Extended release pharmaceutical formulation
EP3881841A4 (en) Pharmaceutical composition
EP3873437A4 (en) Aqueous pharmaceutical formulations
EP3831373A4 (en) Stabilizer-containing solid drug formulation